Trial site
Shenyang
- 15running trials
- 11closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Coronary artery disease4 trials
- Prostate cancer3 trials
- Stroke3 trials
- Chronic myeloid leukaemia2 trials
- Familial hypercholesterolaemia2 trials
- Lupus (SLE)2 trials
- Multiple sclerosis2 trials
- Myeloproliferative neoplasms2 trials
- Sjögren's disease2 trials
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Chronic spontaneous urticaria1 trial
- and 8 more
- Phase
- Phase 317 trials
- Phase 24 trials
- Phase 43 trials
- Phase 2/31 trial
- Status
- Completed10 trials
- Active, not recruiting9 trials
- Recruiting6 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals26 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Recruiting
Recruiting
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Active, not recruiting
Inclisiran Effectiveness in China: a Pragmatic Randomized Trial
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms2 recruiting
- Prostate cancer2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Lupus (SLE)1 recruiting
- Multiple sclerosis1 recruiting
Closed trials
Completed
Completed
Completed
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Completed
Study of Efficacy and Safety of Erenumab in Adult Chronic Migraine Patients
Site data: ClinicalTrials.govUpdated 15 Nov 2026